Through flexible access to our state-of-the-art CRO/CDMO services across the continuum and more than 4,000 scientific experts spanning all disciplines and disease areas, we are working to deliver success for our partners in the most efficient and cost-effective manner. In support of innovators across the entire biotech and pharma R&D economy, we are enabled by a convergence of human ingenuity and state-of-the-art technology for data-driven and AI powered discovery and development of medicines that matter.